Evidence map›Paper›PMID 31475104›Full record

ArticleFrontiers in oncology2019

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy.

Max Fleischmann, Daniel Martin, Samuel Peña-Llopis, Julius Oppermann, Jens von der Grün, Markus Diefenhardt, Georgios Chatzikonstantinou, Emmanouil Fokas, Claus Rödel, Klaus Strebhardt and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Max FleischmannDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Daniel MartinDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Samuel Peña-LlopisDivision of Solid Tumor Translational Oncology, West German Cancer Center, Essen University Hospital, Essen, Germany.
Julius OppermannDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Jens von der GrünDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Markus DiefenhardtDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Georgios ChatzikonstantinouDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Emmanouil FokasDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Claus RödelDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Klaus StrebhardtGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Sven BeckerDepartment of Gynecology, Goethe-University, Frankfurt, Germany.
Franz RödelDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Nikolaos TselisDepartment of Radiotherapy and Oncology, Goethe-University, Frankfurt, Germany.
Goethe University Frankfurt · DEFrankfurt Cancer Institute · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer-specific survivalcaspase 8cervical cancerchemoradiotherapylocal controloverall survivalpolo-like kinase 3

Identifiers

PMID31475104
PMCPMC6702309
OpenAlexW2964326515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.